Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
New ACC/AHA guidelines on chronic coronary disease | How cath labs can become more sustainable
Tuesday, July 25, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

New U.S. guidelines on chronic coronary disease rethink use of beta-blockers, other medications

The updated recommendations from the American College of Cardiology and American Heart Association cover a variety of topics, including patient communication, follow-up imaging, nutritional supplements and more. 

READ MORE >
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
Share on Twitter Share on Facebook Share on Linkedin

New U.S. guidelines on chronic coronary disease rethink use of beta-blockers, other medications

Share on Twitter Share on Facebook Share on Linkedin
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
The updated recommendations from the American College of Cardiology and American Heart Association cover a variety of topics, including patient communication, follow-up imaging, nutritional supplements and more. 
READ MORE >

How cath labs can limit waste and become more sustainable

Making cardiac catheterization labs more efficient and less wasteful could help reduce the large carbon footprint associated with healthcare, according to a new commentary published in JACC: Cardiovascular Interventions.

READ MORE >
Making cardiac catheterization labs (CCLs) more efficient less wasteful could go a long way toward reducing the large carbon footprint associated with healthcare, according to a new commentary published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

How cath labs can limit waste and become more sustainable

Share on Twitter Share on Facebook Share on Linkedin
Making cardiac catheterization labs (CCLs) more efficient less wasteful could go a long way toward reducing the large carbon footprint associated with healthcare, according to a new commentary published in JACC: Cardiovascular Interventions.
Making cardiac catheterization labs more efficient and less wasteful could help reduce the large carbon footprint associated with healthcare, according to a new commentary published in JACC: Cardiovascular Interventions.
READ MORE >

Featured Articles

Permanent pacemakers after TAVR: Tracking the impact of modern self-expanding valves

Researchers explored data from more than 3,000 TAVR patients, presenting their results in JACC: Cardiovascular Interventions. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Permanent pacemakers after TAVR: Tracking the impact of modern self-expanding valves

Share on Twitter Share on Facebook Share on Linkedin
Researchers explored data from more than 3,000 TAVR patients, presenting their results in JACC: Cardiovascular Interventions. 
READ MORE >

New research suggests immunotherapy for AFib could be on the horizon

Targeting immune cells that play a key role in the development of atrial fibrillation could give cardiologists a new way to treat the disease.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New research suggests immunotherapy for AFib could be on the horizon

Share on Twitter Share on Facebook Share on Linkedin
Targeting immune cells that play a key role in the development of atrial fibrillation could give cardiologists a new way to treat the disease.
READ MORE >

In Case You Missed It

Back in the spotlight: Exploring echocardiography's revival

American Society of Echocardiography President Stephen Little, MD, says several trends and technologies are coming together at once, leading to renewed interest in echo.

READ MORE >
Stephen Little, MD, discusses trends in echocardiography at ASE 2023. #ASE23 #ASE2023 What is new in cardiac ultrasound.
Share on Twitter Share on Facebook Share on Linkedin

Back in the spotlight: Exploring echocardiography's revival

Share on Twitter Share on Facebook Share on Linkedin
Stephen Little, MD, discusses trends in echocardiography at ASE 2023. #ASE23 #ASE2023 What is new in cardiac ultrasound.
American Society of Echocardiography President Stephen Little, MD, says several trends and technologies are coming together at once, leading to renewed interest in echo.
READ MORE >

FDA says treating PAD with paclitaxel-coated devices does not increase mortality risk

After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices. 

READ MORE >
Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter. FDA clears new drug eluting balloon, drug-coated balloon.
Share on Twitter Share on Facebook Share on Linkedin

FDA says treating PAD with paclitaxel-coated devices does not increase mortality risk

Share on Twitter Share on Facebook Share on Linkedin
Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter. FDA clears new drug eluting balloon, drug-coated balloon.
After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices. 
READ MORE >

In Other News

Scientists train artificial intelligence to mimic the gaze of radiologists reading images

"This system is bringing with it a greater humanization of AI and therefore a more realistic representation of what we do as radiologists,” one member of the specialty said. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Scientists train artificial intelligence to mimic the gaze of radiologists reading images

Share on Twitter Share on Facebook Share on Linkedin
"This system is bringing with it a greater humanization of AI and therefore a more realistic representation of what we do as radiologists,” one member of the specialty said. 
READ MORE >

Only 38% of patients receive appropriate follow-up care for incidental pulmonary nodules

The findings were derived from 2,500 cases diagnosed between 2018-2019 at an urban tertiary care center and followed for two years afterward.

READ MORE >
lung cancer pulmonary nodule
Share on Twitter Share on Facebook Share on Linkedin

Only 38% of patients receive appropriate follow-up care for incidental pulmonary nodules

Share on Twitter Share on Facebook Share on Linkedin
lung cancer pulmonary nodule
The findings were derived from 2,500 cases diagnosed between 2018-2019 at an urban tertiary care center and followed for two years afterward.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

News Alert: FDA confirms another recall for Impella heart pumps
TAVR in CAD patients: A new approach | Roxana Mehran elected ACC president | Wearable tech company raises $575M
ACC's new president | The fight for safer cath labs | The future of cardiovascular leadership | Focusing on women's health
New stroke prevention device for TAVR holds its own in late-breaking study | FDA clears AI model for pulmonary hypertension
Late-breaking data from ACC.26 | Thousands of insulin pumps recalled | Vascular surgeons make an impact | Voice-based AI tech
Week in Review: Celebrating young leaders | Death sentence confirmed for patient-killing nurse | New cath lab safety standards
Get to know the Cardiovascular Business 40 Under 40 | A historic stroke procedure | Healthcare costs are up—but not survival

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …15
    • Page 16
    • Page 17
    • Page 18
    • Current page 19
    • Page 20
    • Page 21
    • Page 22
    • Page 23 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup